| ACG clinical guidelines: diagnosis and management of celiac disease | American Journal of Gastroenterology | 2013 | 1K |
| The Oslo definitions for coeliac disease and related terms | Gut | 2013 | 992 |
| ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE) | American Journal of Gastroenterology | 2013 | 768 |
| Pathogenesis, diagnosis, and management of cholangiocarcinoma | Gastroenterology | 2013 | 747 |
| Clinical guideline: management of gastroparesis | American Journal of Gastroenterology | 2013 | 672 |
| International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer | Gut | 2013 | 503 |
| Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas | Nature Genetics | 2013 | 464 |
| Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system | Gut | 2013 | 454 |
| Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis | Gut | 2013 | 373 |
| Management of antithrombotic therapy in patients undergoing invasive procedures | New England Journal of Medicine | 2013 | 314 |
| Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis | Gastroenterology | 2013 | 309 |
| CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis | Cancer Cell | 2013 | 306 |
| Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management | Gastroenterology | 2013 | 290 |
| Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice | Gastroenterology | 2013 | 281 |
| Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas | Oncogene | 2013 | 277 |
| Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience | Gut | 2013 | 276 |
| Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis | Nature Genetics | 2013 | 267 |
| Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis | Clinical Gastroenterology and Hepatology | 2013 | 224 |
| A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice | ISME Journal | 2013 | 222 |
| SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells | Oncogenesis | 2013 | 221 |
| Apoptosis and necrosis in the liver | Comprehensive Physiology | 2013 | 212 |
| Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis | American Journal of Gastroenterology | 2013 | 212 |
| Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis | Clinical Gastroenterology and Hepatology | 2013 | 208 |
| Evolving frequency and outcomes of liver transplantation based on etiology of liver disease | Transplantation | 2013 | 197 |
| Classification, diagnosis, and management of cholangiocarcinoma | Clinical Gastroenterology and Hepatology | 2013 | 194 |
